The industry speaks out about how it conducts routine­ and validation­batch blend uniformity testing, to what it attributes failures associated with such tests, and its attitudes toward the use of new blend uniformity testing technologies.
Shilpa Medicare Launches ‘Hybrid CDMO’ at DCAT Week 2025
March 17th 2025This model is being positioned by Shilpa as a dual approach that offers comprehensive discovery, clinical, and commercial outsourcing services in addition to commercially ready, “off-the-shelf” novel formulations for b2b licensing.